Keywords
Etiology
Pathogenesis
Treatment
Submitted : 2024-07-10
Accepted : 2024-07-25
Published : 2024-08-09
Abstract
Premature ovarian failure refers to ovarian function failure in women before the age of 40 years due to follicular depletion or follicular dysfunction resulting in abnormal hormone levels. The etiology and pathogenesis of premature ovarian failure may be related to genetic, immunological, medical, environmental, infectious, psychological and enzyme deficiencies. The treatment involves Western medicine, Chinese medicine, and a combination of Chinese and Western medicine, and the treatment level includes hormone level, cellular level, surgery and psychological aspect. This paper would like to review the progress of the etiology, pathogenesis and treatment of premature ovarian failure in recent years.
References
Chen W, 2021, Analysis of Risk Factors for the Decline of Ovarian Reserve Function and the Development of Premature Ovarian Failure. Modern Medicine and Health Research Electronic Journal, 5(13): 115–117.
Li Y, Yan M, Chen Q, et al., 2022, Current Research on Complementary and Alternative Medicine in the Treatment of Premature Ovarian Failure: An Update Review. Evidence-Based Complementary and Alternative Medicine, 2022: 2574438.
Jiao X, Qin C, Li J, et al., 2012, Cytogenetic Analysis of 531 Chinese Women with Premature Ovarian Failure. Human Reproduction, 27(7): 2201–2207.
Rizzolio F, Pramparo T, Sala C, et al., 2009, Epigenetic Analysis of the Critical Region I for Premature Ovarian Failure: Demonstration of a Highly Heterochromatic Domain on the Long Arm of the Mammalian X Chromosome. Journal of Medical Genetics, 46(9): 585–592.
Portnoi M, Aboura A, Tachdjian G, et al., 2006, Molecular Cytogenetic Studies of Xq Critical Regions in Premature Ovarian Failure Patients. Human Reproduction, 21(9): 2329–2334.
Rafique M, Alobaid S, Al-Jaroudi D, 2019, 47, XXX Syndrome with Infertility, Premature Ovarian Insufficiency, and Streak Ovaries. Clinical Case Reports, 7(6): 1238–1241.
Tang R, Lin L, Guo Z, et al., 2019, Ovarian Reserve Evaluation in a Woman with 45,X/47,XXX Mosaicism: A Case Report and a Review of Literature. Molecular Genetics & Genomic Medicine Med, 7(7): e00732.
Rosario R, Anderson R, 2020, The Molecular Mechanisms that Underlie Fragile X-Associated Premature Ovarian Insufficiency: Is It RNA or Protein Based? Molecular Human Reproduction, 26(10): 727–737.
Huang J, Zhang W, Liu Y, et al., 2019, Association Between the FMR1 CGG Repeat Lengths and the Severity of Idiopathic Primary Ovarian Insufficiency: A Meta-Analysis. A Artificial Cells, Nanomedicine, and Biotechnology, 47(1): 3116–3122.
Ye H, Li X, Zheng T, et al., 2016, The Effect of the Immune System on Ovarian Function and Features of Ovarian Germline Stem Cells. Springerplus, 5(1): 990.
Ayesha, Jha V, Goswami D, 2016, Premature Ovarian Failure: An Association with Autoimmune Diseases. Journal of Clinical and Diagnostic Research, 10(10): Qc10–Qc12.
Xue Q, Zeng C, Zhou Y, 2015, Gynaecological Surgery and Radiotherapy and Premature Ovarian Failure. Chinese Journal of Practical Gynaecology and Obstetrics, 31(8): 713–717.
Wallin E, Falconer H, Radestad A, 2019, Sexual, Bladder, Bowel and Ovarian Function 1 Year After Robot-Assisted Radical Hysterectomy for Early-Stage Cervical Cancer. Acta Obstetricia et Gynecologica Scandinavica, 98(11): 1404–1412.
Akdemir Y, Akpolat M, Elmas O, et al., 2022, Capsaicin Prevents Radiotherapy-Induced Premature Ovarian Failure in Rats. Reproduction, Fertility and Development, 34(3): 350–361.
He L, Long X, Yu N, et al., 2021, Premature Ovarian Insufficiency (POI) Induced by Dynamic Intensity Modulated Radiation Therapy via P13K-AKT-FOXO3a in Rat Models. BioMed Research International, 2021: 7273846.
Wang Q, Stringer J, Liu J, et al., 2019, Evaluation of Mitochondria in Oocytes Following Gamma-Irradiation. Scientific Reports, 9(1): 19941.
Petru E, 2010, Fertility Preservation and Infertility Treatment in Breast Cancer Patients. Wiener Medizinische Wochenschrift, 160(19–20): 487–492.
Liu Y, Zhang D, 2016, Construction and Comparison of Four Drug-Induced Premature Ovarian Failure Mouse Models. 2016 National Academic Symposium on Progress of Research in Integrated Chinese and Western Medicine Obstetrics and Gynaecology and 2016 First Jiangsu, Zhejiang and Shanghai Integrated Chinese and Western Medicine Obstetrics and Gynaecology Summit Forum, 2016: 120–121.
Spears N, Lopes F, Stefansdottir A, et al., 2019, Ovarian Damage from Chemotherapy and Current Approaches to Its Protection. Human Reproduction Update, 25(6): 673–693.
Yoon S, Yoon J, Park M, et al., 2020, Recovery of Ovarian Function by Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells in Cisplatin-Induced Premature Ovarian Failure in Mice. Stem Cell Research & Therapy, 11(1): 255.
Xiao S, Zhang J, Liu M, et al., 2017, Doxorubicin Has Dose-Dependent Toxicity on Mouse Ovarian Follicle Development, Hormone Secretion, and Oocyte Maturation. Toxicological Sciences, 157(2): 320–329.
Budani M, Tiboni G, 2017, Ovotoxicity of Cigarette Smoke: A Systematic Review of the Literature. Reproductive Toxicology, 2017(72): 164–181.
Li F, Ding J, Cong Y, et al., 2020, Trichostatin A Alleviated Ovarian Tissue Damage Caused by Cigarette Smoke Exposure. Reproductive Toxicology, 2020(93): 89–98.
Yan J, Li RQ, Wang HR, et al., 2020, Potential Influence of COVID-19/ACE2 on the Female Reproductive System. Molecular Human Reproduction, 26(6): 367–373.
Pellicer A, Miro F, Sampaio M, et al., 1991, In Vitro Fertilization as a Diagnostic and Therapeutic Tool in a Patient with Partial 17,20-Desmolase Deficiency. Fertility and Sterility, 55(5): 970–975.
Maheshwari M, Arya S, Lila A, et al., 2022, 17Alpha-Hydroxylase/17,20-Lyase Deficiency in 46,XY: Our Experience and Review of Literature. Journal of the Endocrine Society, 6(3): bvac011.
Masunaga Y, Mochizuki M, Kadoya M, et al., 2021, Primary Ovarian Insufficiency in a Female with Phosphomannomutase-2 Gene (PMM2) Mutations for Congenital Disorder of Glycosylation. Endocrine Journal, 68(5): 605–611.
Liu L, Wang H, Xu G, et al., 2021, Tet1 Deficiency Leads to Premature Ovarian Failure. Frontiers in Cell and Developmental Biology, 2021(9): 644135.
Mardesic T, Jelinkova L, Melicharova L, 2017, Successful Ovarian Tissue Transplantation in Woman with Premature Ovarian Failure After Gonadotoxic Treatment. Journal archive Czech Gynaecology, 82(1): 38–41.
Wu L, 2021, The Value of Psychological Care in the Care of Patients with Premature Ovarian Failure. China Medical Guide, 19(35): 160–161.
Chen M, He Q, Guo J, et al., 2022, Electro-Acupuncture Regulates Metabolic Disorders of the Liver and Kidney in Premature Ovarian Failure Mice. Front Endocrinol (Lausanne), 2022(13): 882214.
Jiang M, 2020, Observation on the Clinical Effect of Chinese Medicine in Treating Premature Ovarian Failure. Practical Gynaecological Endocrinology Electronic Journal, 7(32): 20–21.